BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipopolysaccharide
,
rs2230926
,
ERBB2
,
nitric oxide metabolic process
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
virus reassortant
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Lungs of mice infected with 1918, K173 or reassortant H1N1 influenza viruses
Early and sustained innate immune response to highly pathogenic influenza virus
PBMCs infected with virulent Lassa fever virus (LASV) or live attenuated M29 reassortant
Macrophages infected with Vietnamese, Indonesian, and recombined H5N1 influenza A
Lungs of mice infected with H1N1 influenza A and treated with complete Freund’s adjuvant (CFA)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for virus reassortant
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Health…
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Health…
A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Se…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ